The management of lateral pelvic lymph nodes in locally advanced lower rectal cancer remains controversial. The sentinel lymph node (SLN) mapping can potentially enhance patient selection for lateral ...

Hepatocellular carcinoma (HCC) is a major global health issue, with significant morbidity and mortality rates. As the sixth most common cancer and the third leading cause of cancer-related deaths, HCC ...

Fluorescence-guided surgery has emerged as an innovative technique with promising applications in the treatment of various tumors, including colon cancer. Tumor-initiating probe yellow (TiY) has been ...

Reliable detection of Merkel cell polyomavirus in Merkel cell carcinoma by whole exome next-generation sequencing. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract ...

A high-level live operative surgical workshop titled “Illuminating Precision: Advances in Fluorescence-Guided Surgery” threw light on the evolving role of Fluorescence-Guided Surgery (FGS) in the ...

MADISON, Wis.--(BUSINESS WIRE)--OnLume Inc., a Madison, Wisconsin-based medical imaging company with unique technology for improving surgical precision in the operating room, has announced the start ...

The research team of Prof. Hyun Koo Kim of the Department of Thoracic and Cardiovascular Surgery, Korea University's Guro Hospital, has developed "precise and safe pulmonary segmentectomy enabled by ...

Figure 1: Panel of various pediatric tumors comparing H&E staining, FRα, and FRβ protein expression within the tumor. None of these tumors demonstrate FRα expression; however all of the tumors ...

Cutting-edge surgical tools are often made with state-of-the-art technology, which can limit their overall accessibility. In an effort to expand surgical options for tumor removal, a team is ...

For the first time, a fluorescent-guided nerve imaging agent shows promise for use in humans, according to a paper published in Nature Communications. The study sought to evaluate the safety of ...

Researchers from Sagittide Therapeutics Co. Ltd. and Shanghai Jiao Tong University have presented results of early studies with a novel MUC1-C-targeted near-infrared imaging agent – SAG-602 – for ...